PHX Reporter

The Arizona House of Representatives has approved HB2871, a bill aimed at funding clinical research on ibogaine for veterans suffering from traumatic brain injury (TBI) and post-traumatic stress disorder (PTSD). Sponsored by State Representative Justin Wilmeth, the bill allocates $5 million for a certified clinical study and received bipartisan support. It now advances to the Senate.

Representative Wilmeth emphasized the urgency of the issue, stating, "Every single day, we lose veterans to PTSD and traumatic brain injuries, and the treatment options available now just aren’t good enough." He called on Senate colleagues to pass HB2871, adding, "Let’s make Arizona the leader in real solutions for our veterans."

The bill tasks the Arizona Department of Health Services with awarding a grant to a research institution experienced in neurological studies. This will facilitate certified clinical research on ibogaine's effects on TBI and PTSD. The funding is secured by exempting it from lapsing.

Ibogaine has been noted for its potential benefits in reducing PTSD symptoms and repairing neurological damage. Veterans such as Texas Congressman Morgan Luttrell and retired SEAL Marcus Luttrell have credited ibogaine with aiding their recovery from combat-related issues.

Former U.S. Senator Kyrsten Sinema supported HB2871 before the House Appropriations Committee and committed to raising an additional $5 million in private funds to match state investment.

Justin Wilmeth represents Legislative District 2 in North Phoenix as a Republican member of the Arizona House of Representatives. Follow him on X at @JustinWilmethAZ.

Information from this article can be found here.